Skip to main content

Table 2 Treatment Information of the study patients

From: The burden of unrecognised chronic kidney disease in patients with type 2 diabetes at a county hospital clinic in Kenya: implications to care and need for screening

Variable

Proportion, N (%)

Diabetes mellitus treatment

 Diet-only

11 (2.9)

 Oral Glucose-lowering Agents(OGLAs)-only

262 (68.1)

 Insulin-only

66 (17.1)

 Insulin combined with Oral Glucose-lowering Agents

46 (12.0)

Other co-medications used regularly by the subjects

 Anti-platelets

45 (11.7)

 Statins

48 (12.5)

 Anti-platelets and statins

108 (28.1)

 Anti-hypertensive drugs

295 (76.6)

 - ACEi/ARBs

204 (69.0)

Frequency of clinic attendance in the last 12 months

 2–3

68 (17.7)

 4–5

292 (75.9)

 6 and above

25 (6.5)

  1. ACEi Angiotensin Converting Enzyme inhibitors, ARBs Angiotensin Receptor Blockers